Close Menu


News on bioinformatics, software, genome analysis, variant classification, and IT in genetics, genomics, and molecular diagnostics.

The technology vendor and the PBM will offer a bundled platform to help guide cancer patients to the most appropriate treatments.

The Swedish bioinformatics firm sees its greatest growth potential in precision cancer diagnostics as it prepares to go public in the next 12 months.

The companies initially plan to expand the commercialization of Sophia's DDM analytics platform and Hitachi's digital healthcare technology in certain geographic areas.

The California-based firms also plan to collaborate on advancing genomics and artificial intelligence-guided oncology tools. 

In a keynote to the AMIA Informatics Summit, the NCI director said precision oncology has created new challenges in data analysis and management.